Log in
NYSE:MET

MetLife Stock Forecast, Price & News

$37.85
+0.54 (+1.45 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$36.80
Now: $37.85
$37.86
50-Day Range
$35.75
MA: $38.46
$40.94
52-Week Range
$22.85
Now: $37.85
$53.28
Volume6.51 million shs
Average Volume6.58 million shs
Market Capitalization$34.36 billion
P/E Ratio4.92
Dividend Yield4.93%
Beta1.28
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More
MetLife logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 3.0Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.24 out of 5 stars

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500
Employees49,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$5.68 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Market Cap$34.36 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$37.85
+0.54 (+1.45 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MetLife (NYSE:MET) Frequently Asked Questions

How has MetLife's stock price been impacted by COVID-19?

MetLife's stock was trading at $33.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MET stock has increased by 13.7% and is now trading at $37.85.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of MetLife?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for MetLife
.

When is MetLife's next earnings date?

MetLife is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for MetLife
.

How can I listen to MetLife's earnings call?

MetLife will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) released its earnings results on Wednesday, August, 5th. The financial services provider reported $0.83 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.90 by $0.07. The financial services provider had revenue of $13.85 billion for the quarter, compared to analyst estimates of $15.36 billion. MetLife had a net margin of 10.65% and a return on equity of 7.71%.
View MetLife's earnings history
.

How often does MetLife pay dividends? What is the dividend yield for MetLife?

MetLife declared a quarterly dividend on Tuesday, October 20th. Investors of record on Tuesday, November 3rd will be given a dividend of $0.46 per share on Monday, December 14th. This represents a $1.84 annualized dividend and a yield of 4.86%. The ex-dividend date is Monday, November 2nd.
View MetLife's dividend history
.

How will MetLife's stock buyback program work?

MetLife declared that its Board of Directors has approved a share buyback plan on Thursday, November 1st 2018, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4.6% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its shares are undervalued.

What price target have analysts set for MET?

8 equities research analysts have issued 12 month target prices for MetLife's shares. Their forecasts range from $32.00 to $47.00. On average, they expect MetLife's share price to reach $41.17 in the next year. This suggests a possible upside of 8.8% from the stock's current price.
View analysts' price targets for MetLife
.

Are investors shorting MetLife?

MetLife saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 9,760,000 shares, a drop of 16.9% from the August 31st total of 11,740,000 shares. Based on an average trading volume of 5,530,000 shares, the short-interest ratio is currently 1.8 days. Approximately 1.3% of the company's shares are short sold.
View MetLife's Short Interest
.

Who are some of MetLife's key competitors?

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MetLife investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), General Electric (GE), International Business Machines (IBM), Exxon Mobil (XOM), Intel (INTC), Johnson & Johnson (JNJ), Cisco Systems (CSCO) and JPMorgan Chase & Co. (JPM).

Who are MetLife's key executives?

MetLife's management team includes the following people:
  • Mr. Michel Abbas Khalaf, CEO, Pres & Director (Age 56, Pay $5.79M)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 46, Pay $3.46M)
  • Mr. Bill Pappas, Exec. VP and Head of Global Technology & Operations (Age 50, Pay $2.3M)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 61, Pay $3.22M)
  • Mr. Ramy Tadros, Exec. VP & Pres of U.S. Bus. (Age 44, Pay $2.6M)

What is MetLife's stock symbol?

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are MetLife's major shareholders?

MetLife's stock is owned by a number of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (0.60%), LSV Asset Management (0.38%), Prudential PLC (0.24%), Artemis Investment Management LLP (0.24%), Robeco Institutional Asset Management B.V. (0.18%) and Envestnet Asset Management Inc. (0.16%). Company insiders that own MetLife stock include Carlos M Gutierrez, Catherine R Kinney, John D Mccallion and Steven J Goulart.
View institutional ownership trends for MetLife
.

Which institutional investors are selling MetLife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Crawford Investment Counsel Inc., Pzena Investment Management LLC, Shufro Rose & Co. LLC, Douglas Lane & Associates LLC, Prudential PLC, Wedge Capital Management L L P NC, and Ferguson Wellman Capital Management Inc.. Company insiders that have sold MetLife company stock in the last year include Catherine R Kinney, and Steven J Goulart.
View insider buying and selling activity for MetLife
.

Which institutional investors are buying MetLife stock?

MET stock was acquired by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Envestnet Asset Management Inc., Adams Diversified Equity Fund Inc., Moloney Securities Asset Management LLC, Toronto Dominion Bank, Alaska Permanent Fund Corp, Farmers Trust Co., and Polianta Ltd.
View insider buying and selling activity for MetLife
.

How do I buy shares of MetLife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MetLife's stock price today?

One share of MET stock can currently be purchased for approximately $37.85.

How big of a company is MetLife?

MetLife has a market capitalization of $34.36 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. MetLife employs 49,000 workers across the globe.

What is MetLife's official website?

The official website for MetLife is www.metlife.com.

How can I contact MetLife?

MetLife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.